SCHEMBL387994

SCHEMBL387994

[CH]=CCCC(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22804160 1.00
SCHEMBL386228 0.84
SCHEMBL2118230 0.82 LMNA (0.35)
SCHEMBL383882 0.81
SCHEMBL28031047 0.80 LMNA (0.33)
SCHEMBL20503133 0.80 LMNA (0.33)
SCHEMBL2118221 0.77 ACE2 (0.36)
SCHEMBL5153807 0.76
SCHEMBL28922715 0.75 ACE2 (0.44)
SCHEMBL27483485 0.75 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139926-A Resin composition 株式会社可乐丽 2024-06-04 CN disclosed
CN-118139909-A Beta-methyl-delta-valerolactone based polymer 株式会社可乐丽 2024-06-04 CN disclosed
US-20230250218-A1 URETHANE COMPOSITION NITTO KASEI CO., LTD. (JP) 2023-08-10 US disclosed
EP-4198068-A1 URETHANE COMPOSITION Nitto Kasei Co., Ltd. (JP) 2023-06-21 EP disclosed
WO-2023068345-A1 Β-METHYL-δ-VALEROLACTONE POLYMER 株式会社クラレ 2023-04-27 WO disclosed
WO-2023068346-A1 Β-METHYL-δ-VALEROLACTONE POLYMER 株式会社クラレ 2023-04-27 WO disclosed
WO-2023068348-A1 RESIN COMPOSITION 株式会社クラレ 2023-04-27 WO disclosed
CN-116018365-A Carbamate composition 日东化成株式会社 2023-04-25 CN disclosed
EP-2444401-B1 NOVEL IMIDAZOPYRIDINE COMPOUND ONO PHARMACEUTICAL CO (JP) 2014-09-03 EP disclosed
US-8569504-B2 Imidazopyridine compound ONO PHARMACEUTICAL CO., LTD. (JP) 2013-10-29 US disclosed
EP-0634172-A1 DERMATOLOGIC PREPARATION COMPOSITION CONTAINING PROSTACYCLIN AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1995-01-18 EP disclosed
EP-0634171-A1 PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS TEIJIN LIMITED (JP) 1995-01-18 EP disclosed
US-5302317-A Halobenzene liquid crystals HOFFMANN-LA ROCHE INC. (US) 1994-04-12 US disclosed
EP-0315014-B1 Halogenated benzene derivatives HOFFMANN LA ROCHE (CH) 1994-01-12 EP disclosed
EP-0315050-B1 ALCENYL BICYCLOHEXANES F. HOFFMANN-LA ROCHE AG (CH) 1993-09-01 EP disclosed
US-5230826-A HALOBENZENE LIQUID CRYSTALS HOFFMANN-LA ROCHE INC. (US) 1993-07-27 US disclosed
US-5013477-A Alkenylbicyclohexane liquid crystals HOFFMANN-LA ROCHE INC. (US) 1991-05-07 US disclosed
EP-0315014-A2 Halogenated benzene derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-05-10 EP disclosed
EP-0315050-A2 Alcenyl bicyclohexanes F. HOFFMANN-LA ROCHE AG (CH) 1989-05-10 EP disclosed
US-3989744-A STIMULATES SMOOTH MUSCLES, PROSTAGLANDINS MILES LABORATORIES, INC. (US) 1976-11-02 US disclosed